APOE and Alzheimer disease: As expectedly, significantly more AD were APOE ε4+ than NC and E-MCI group (P<0.01): 114 of162 AD participants (70.4%) showing one or more ε4 allele relative to 55 of 211 NC participants (26.6%) and 189 of 346 E-MCI participants (54.6%).